Peer Review History
| Original SubmissionMay 9, 2025 |
|---|
|
Dear Dr. Adewuyi Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process, by the Editor and the reviewers Please submit your revised manuscript by Nov 01 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Hannah Mafo Degge, Ph.D Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating in your Funding Statement: “EOA was supported by the National Health and Medical Research Council (NHMRC; https://www.nhmrc.gov.au/) Investigator grants (GNT2025837). The funder has no role in the conduct of this study.” Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now. Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf. 3. We note that you have indicated that there are restrictions to data sharing for this study. For studies involving human research participant data or other sensitive data, we encourage authors to share de-identified or anonymized data. However, when data cannot be publicly shared for ethical reasons, we allow authors to make their data sets available upon request. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Before we proceed with your manuscript, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible. Please update your Data Availability statement in the submission form accordingly. 4. We note that Figure 1 in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright. We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission: a. You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license. We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text: “I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.” Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission. In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year]. b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only. The following resources for replacing copyrighted map figures may be helpful: USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/ The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/ Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/ Landsat: http://landsat.visibleearth.nasa.gov/ USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/# Natural Earth (public domain): http://www.naturalearthdata.com/ If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments : Introduction This section could benefit with some critical appraisal e.g Line 86-87; you mentioned the MSS and conditional cash transfers; however MSS was not sustained and conditional cash transfer was not widespread; provide a critical analysis of this and its probable contribution to differential outcomes across states/regions line 97- home birth in Nigeria and LMICs; home birth in Nigeria is currently mostly TBA provided or unsupervised ‘SBA’, this is the core of your paper, hence will be useful to note this, and explore the whys of the contributions of these two ‘providers’ to poor maternal outcomes, including briefly touching why women will opt for a home birth based on past literature ( be careful when doing this in not giving too much away) as this is the focus of your research line 161 –it will be useful to provide specific maternal health initiative that align with global health rather than just saying ‘some initiatives… Discussion You mentioned using the theoretical frameworks Andersen’s Behavioural Model of Healthcare- this has not been integrated or applied explicitly in your discussion; will be beneficial to do this and not just limit to using it in identifying your explanatory variable. Consider how you can apply this to strengthen your discussion line 375-376- decline mentioned is from which data, kindly indicate what, and/or is it the previous DHS and why might this decrease have happened? Lines 380-382; similar to line 97-99 your introduction- possible repetition? Line 384-385, explore further why urban residence alone does not guarantee for that region Line 389- what constrained options? This is too vague, kindly provide details/examples Line 396- you wrote “This premise also supports the urgent need for a social justice approach—one that goes beyond individual-level interventions to confront systemic barriers.” Elaborate on what you mean by social justice approach in the context of your study Lines 436-439; you wrote “birth among women in the middle wealth category in urban settings only, possibly reflect the reality of urban poverty, where families live in informal settlements or slums, underserved by health infrastructure, or the erosion of the middle class in urban Nigeria” This is too long, kindly split and rephrase to improve clarity Lines 464-467- some critical analysis required in your suggestion on digital inclusion and integration of internet access into maternal health; will this not widen the existing health inequality, considering digital inclusion means access to smart phones- in the current climate of lack of basic infrastructure including electricity, poor internet connectivity, high cost of internet services; is this feasible across all states and all regions? Kindly note it is not just about suggesting policy that promote digital inclusion, what about the enabling factors to allow for the implementation of the policy, provide a crtiical discourse on this point Line 475-477 you wrote “The markedly higher odds of home birth in the rural North-West and South-South may also exemplify how rurality and regional deprivation intersect to perpetuate maternal health disparities”. Kindly expand on what you mean – noting the keen differences in North and South of Nigeria Policy and programmatic implications The way you have listed them all out in this section, your implications all appear like the typical suggestions. Going forward in rewriting this section; a critical consideration of feasibility will be beneficial in presenting this. Also, it is good for you to focus on innovative means (cost effective, community driven initiatives) that could be employed: Consider the MSS that was started and abandoned due to number of reasons, including lack of collaboration from all partners. How can MSS be revamped and resuscitated? How do we address the user fee issue that limits access? What innovative community driven financial scheme can be used by women to address the use of user fee? In considering the systemic/structural issues, what can you learn from the Abiye programme in Ondo state, why did it succeed and why has it gone down? What take home point can you use from this in addressing the systemic/structural issues Still in line with above, controlling all other factors (like culture, ethnicity, or religion), the bottom line to the poor maternal outcome is the absence of good maternal health care system(systemic/strucutral factors) that meets the requirement of UHC (hence the need to look at the Abiye as mentioned above) what lessons can we learn and apply Finally, since you used the social justice lens, kindly organise this section along that line so it does not appear like a ‘textbook prescription’, Minor corrections Proofread and review for typo errors. E.g check your acknowledgement line 562, what is figs? Kindly refrain from the use of dash (-) in academic writing it sets an informal tone, and it is associated with AI generated work [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** Reviewer #1: 1. Since you are using the Andersen model, kindly provide a brief description of the healthcare facility distribution in Nigeria (e.g., availability across states). 2. Line 185: Ethical approval was granted by the Nigerian National Health Research Ethics Committee, could you provide the ethical approval reference number from the Nigerian National Health Research Ethics Committee for this study? 3. Table 1, the wording used for the enabling factors included was quite informal: "Distance to health facility (big problem/not a big problem)" "Permission to visit health facility (big problem/not a big problem)" "Getting money for health services (big problem/not a big problem)". Suggested revisions: Difficulty due to distance (Yes/No) Decision-making autonomy (Independent/Requires permission) Affordability issue (Yes/No) 4. Table 2: Would you consider rearranging the order of the variables based on domain in Andersen model (to be similar to the order in Table 1)? 5. Table 2: Please consider adding a p-value column for clarity. 6. Line 454: Higher-parity women have higher odds of home birth; Line 502, Younger women have higher odds of home birth. However, younger women usually have lower parity, while higher-parity mothers are older. Could you reconcile or further explain these findings? 7. Line 500: You noted higher odds of home births among Muslim mothers. Could you provide supporting evidence on Muslim perspectives toward maternal health services in Nigeria, since you suggest culturally sensitive services? Reviewer #2: as far as i searched the study is original research and not published else where. starting from the research topic it is impactful and pertinent issue but I have doubt on its novelty. since it was done before based on 2013 Nigeria demographic and health survey , it needs pertinent justification. even if conclusion lacks some reference data but recommendations were stated based on the finding data better to select pertinent keywords in the abstract part introduction part is well written but significant impact of home birth not mentioned briefly add reference at the end of 1st paragraph of introduction part line number 87-89 in Methods part how informed consent was applicable from secondary data? how do you get the participant? line number 185-187) operational definition should included in the method part to clarify some variables like rich house hold and poor house hold discussion part is well written and appreciated Reviewer #3: General remarks about the manuscript This manuscript tackles a crucial public health issue—the ongoing challenge of home births in Nigeria and the disparities that exist between rural and urban regions. Utilizing a substantial, national dataset to examine these variations is a notable strength of the study. The emphasis on identifying related factors is particularly pertinent for shaping public health policies and interventions. The manuscript is well-articulated, and the research question is clearly defined. My following observations are aimed at enhancing the paper and preparing it for publication. Specific comments 1. In result part of your abstract add confidence interval and p- value for all prevalence value or remove all, it is better to be similar. And also better to add p- Value and CI for the AOR value of significant variables and home birth. 2. Maternal morbidity and mortality, which are the results of home delivery, are discussed in the first paragraph of your introduction. But your first paragraph of introduction part is better to deal about home birth and the consequence of it in globally. Therefore, it is preferable to eliminate the first paragraph or reorganize the introduction's sequence. 3. In your methodology part, the total 41,821 mothers were surveyed, but you take only 21,512 mothers why? Or how can you select those sampled mothers? 4. In your analysis section, you assess the multicollinearity assumption, which is good, but what about other other logistic regression assumptions like outlier detection, the Hosmer and Lemeshow test, and the independence of observations? 5. In you discussion part, the manuscript title highlights a comparative analysis between rural and urban settings. The discussion should not only present these differences but also delve into the potential underlying reasons for them. For instance, are the rural-urban disparities due to differences in healthcare infrastructure, socioeconomic status, cultural beliefs, or a combination of these factors? A deeper interpretation would significantly strengthen the findings. 6. Ensure consistent use of terminology throughout the manuscript. For example, "home birth" and "childbirth outside health facilities" appear to be used interchangeably. A single, clear definition at the beginning of the manuscript would be beneficial. Reviewer #4: Thank you for the opportunity to review this excellent and important paper. Overall, I think it is well done. I do have some concerns that this paper was published with data from Nigeria without any authors who have an affiliation in Nigeria. I understand that maybe there are connections to Nigeria that I am not aware of but would like it to be addressed and explicitly stated if there is. If not, I would like to see this addressed in the limitations or potentially adding a reflexivity statement https://gh.bmj.com/content/9/1/e014743. Line 81-specify "maternal and neonatal" mortality rates Line 85-it is not just extremely high but the highest of any country in the world, I think this should be added. Line 88-Nonetheless, maternal and neonatal mortality remain unacceptably high in Nigeria, with the continued prevalence of home births emerging as a likely key contributing factor. -this should be referenced. line 99-lack of skilled birth attendants is also a significant factor here based on data and should be specifically called out. line 101- Hence, ensuring facility-based births with access to emergency care remains essential to reducing these deaths. you should add and access to skilled birth attendants here I really love this dual approach -This dual lens shifts the focus beyond individual behaviours to systemic 137 constraints in maternal healthcare access. the methods are sound and well done Line 391-also women not be empowered also likely plays a role here and should be called out here as well as later when you discuss it more I would also add a line in the conclusions tying back in the maternal and newborn mortality to remind the readers why it is important to address home births. Very nice job with this paper ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Lubaba Ahmed Mohammed Reviewer #3: No Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 1 |
|
Dear Dr. Adewuyi, Thank you for revising and resubmitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. And there are few minor revisions required to achieve this standard. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== ACADEMIC EDITOR: Address the following 1. Repetition observed in lines 91-94 and 193-194 "91 In response to this ongoing challenge, the Nigerian government has introduced several initiatives 92 aimed at increasing access to skilled care and improving maternal and newborn outcomes. These 93 initiatives include the Midwives Service Scheme (MSS), conditional cash transfers (CCTs), and the Basic 94 Health Care Provision Fund (BHCPF) [15-22]". "193 To improve maternal and neonatal health and align with global health goals, the Nigerian government 194 has implemented initiatives such as the MSS, CCTs and BHCPF [15-18, 20-22]." Consider merging this last paragraph under Study Setting with the paragraph above it and reframing lines 193-194 to read something like this: "Despite the Nigerian government’s efforts to improve maternal and neonatal health in line with global health goals, through initiatives such as the MSS, CCTs, and BHCPF mentioned earlier; poor maternal and neonatal health outcomes continue to persist" 2. Sentence in line 235-236 should be in past tense, amend accordingly 235 We adopt Andersen’s Behavioural Model as the conceptual framework and utilise the model in 236 selecting explanatory variables Please submit your revised manuscript by Dec 03 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Hannah Mafo Degge, Ph.D Academic Editor PLOS ONE Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Editor's comments SEE ABOVE [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Home birth and associated factors in Nigeria: a comparative study of rural and urban settings—analysis of national population-based data PONE-D-25-25157R2 Dear Dr. Adewuyi, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Hannah Mafo Degge, Ph.D Academic Editor PLOS ONE |
| Formally Accepted |
|
PONE-D-25-25157R2 PLOS ONE Dear Dr. Adewuyi, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Hannah Mafo Degge Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .